--- title: "Aramark To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday" type: "News" locale: "en" url: "https://longbridge.com/en/news/286267446.md" description: "Top Wall Street analysts have updated their ratings on several companies. Baird raised Aramark's price target from $50 to $58, maintaining an Outperform rating, while Aramark shares closed at $48.41. Other notable changes include BMO Capital increasing Nextpower's target from $113 to $125, and Mizuho cutting Agree Realty's target from $86 to $80. Analysts also adjusted targets for companies like Arvinas, Intellia Therapeutics, and Hims & Hers Health. For a complete list of changes, see the analyst ratings page." datetime: "2026-05-13T13:03:54.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286267446.md) - [en](https://longbridge.com/en/news/286267446.md) - [zh-HK](https://longbridge.com/zh-HK/news/286267446.md) --- # Aramark To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. - BMO Capital raised the price target for **Nextpower Inc** (NASDAQ:NXT) from $113 to $125. BMO Capital analyst Ameet Thakkar maintained a Market Perform rating. Nextpower shares closed at $125.37 on Tuesday. See how other analysts view this stock. - Baird boosted **Aramark** (NYSE:ARMK) price target from $50 to $58. Baird analyst Andrew Wittmann maintained an Outperform rating. Aramark shares closed at $48.41 on Tuesday. See how other analysts view this stock. - Mizuho cut price target for **Agree Realty Corp** (NASDAQ:ADC) from $86 to $80. Mizuho analyst Haendel St. Juste maintained a Neutral rating. Agree Realty shares closed at $76.54 on Tuesday. See how other analysts view this stock. - BTIG raised the price target for **Arvinas Inc** (NASDAQ:ARVN) from $16 to $18. BTIG analyst Jeet Mukherjee maintained a Buy rating. Arvinas shares closed at $9.57 on Tuesday. See how other analysts view this stock. - HC Wainwright & Co. cut **Intellia Therapeutics Inc** (NASDAQ:NTLA) price target from $30 to $25. HC Wainwright & Co. analyst Mitchell S. Kapoor maintained a Buy rating. Intellia Therapeutics shares closed at $13.99 on Tuesday. See how other analysts view this stock. - B of A Securities slashed **Hims & Hers Health Inc** (NYSE:HIMS) price target from $32 to $30. B of A Securities analyst Allen Lutz maintained a Neutral rating. Hims & Hers Health shares closed at $25.03 on Tuesday. See how other analysts view this stock. - Truist Securities raised **Sensata Technologies Holding PLC** (NYSE:ST) price target from $43 to $58. Truist Securities analyst William Stein upgraded the stock from Hold to Buy. Sensata Technologies shares closed at $44.51 on Tuesday. See how other analysts view this stock. - Mizuho cut the price target for **Zoominfo Technologies Inc** (NASDAQ:GTM) from $10 to $3. Mizuho analyst Siti Panigrahi downgraded the stock from Neutral to Underperform. Zoominfo shares closed at $4.06 on Tuesday. See how other analysts view this stock. - Keybanc cut **Aecom** (NYSE:ACM) price target from $115 to $101. Keybanc analyst Sangita Jain maintained an Overweight rating. Aecom shares closed at $69.95 on Tuesday. See how other analysts view this stock. - Rosenblatt raised **Arteris Inc** (NASDAQ:AIP) price target from $20 to $38. Rosenblatt analyst Kevin Cassidy maintained a Buy rating. Arteris shares closed at $32.43 on Tuesday. See how other analysts view this stock. Considering buying ARMK stock? Here’s what analysts think: Photo via Shutterstock ### Related Stocks - [ARMK.US](https://longbridge.com/en/quote/ARMK.US.md) - [HIMS.US](https://longbridge.com/en/quote/HIMS.US.md) - [HIMY.US](https://longbridge.com/en/quote/HIMY.US.md) - [EATZ.US](https://longbridge.com/en/quote/EATZ.US.md) - [HIMZ.US](https://longbridge.com/en/quote/HIMZ.US.md) - [NXT.US](https://longbridge.com/en/quote/NXT.US.md) - [ADC.US](https://longbridge.com/en/quote/ADC.US.md) - [ARVN.US](https://longbridge.com/en/quote/ARVN.US.md) - [NTLA.US](https://longbridge.com/en/quote/NTLA.US.md) - [ST.US](https://longbridge.com/en/quote/ST.US.md) - [GTM.US](https://longbridge.com/en/quote/GTM.US.md) - [ACM.US](https://longbridge.com/en/quote/ACM.US.md) - [AIP.US](https://longbridge.com/en/quote/AIP.US.md) - [ADC-A.US](https://longbridge.com/en/quote/ADC-A.US.md) ## Related News & Research - [Hims & Hers Health Posts Mixed Q1 Amid Weight-Loss Product 'Noise': Analysts](https://longbridge.com/en/news/286130715.md) - [BUZZ-Hims & Hers Health shares stabilize after boosted $350 mln convertible deal](https://longbridge.com/en/news/286896810.md) - [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md) - [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md) - [Earnings Beat: Deepak Nitrite Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models](https://longbridge.com/en/news/286980047.md)